Global hepatitis C elimination: an investment framework

Alisa Pedrana*, Jessica Howell, Nick Scott, Sophia Schroeder, Christian Kuschel, Jeffrey V. Lazarus, Rifat Atun, Ricardo Baptista-Leite, Ellen ‘t Hoen, Sharon J. Hutchinson, Lisa Aufegger, Raquel Peck, Annette H. Sohn, Tracy Swan, Mark Thursz, Olufunmilayo Lesi, Manik Sharma, John Thwaites, David P. Wilson, Margaret Hellard

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)
225 Downloads (Pure)


WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment in elimination programmes remains low. To help drive political commitment and catalyse domestic and international financing, we have developed a global investment framework for the elimination of hepatitis B and hepatitis C. The global investment framework presented in this Health Policy paper outlines national and international activities that will enable reductions in hepatitis C incidence and mortality, and identifies potential sources of funding and tools to help countries build the economic case for investing in national elimination activities. The goal of this framework is to provide a way for countries, particularly those with minimal resources, to gain the substantial economic benefit and cost savings that come from investing in hepatitis C elimination.
Original languageEnglish
Pages (from-to)927-939
Number of pages13
JournalThe Lancet Gastroenterology & Hepatology
Issue number10
Early online date27 Jul 2020
Publication statusPublished - Oct 2020


  • WHO global target
  • elimination
  • hepatitis c
  • hepatitis B

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology


Dive into the research topics of 'Global hepatitis C elimination: an investment framework'. Together they form a unique fingerprint.

Cite this